1UC Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Cue Biopharma Inc

Watchlist Manager

Watchlist

Price: 25.92 EUR 7.82%

Market Cap: €1.3B

C	Cue Biopharma Inc F:1UC	US
	Emergent Metals Corp XTSX:EMR	CA
	Seche Environnement SA PAR:SCHP	FR
C	China Education Resources Inc XTSX:CHN	CA
	Societe Francaise de Casinos SA PAR:SFCA	FR
	BP Silver Corp XTSX:BPAG	CA
R	Resqunit AB (publ) F:Z16	SE
	Candelaria Mining Corp XTSX:CAND	CA
I	Italy Innovazioni SpA PAR:MLITN	IT

Profitability Summary

Cue Biopharma Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-60%

Negative 3Y Average Operating Margin

-570%

Operating Margin is Increasing

-2 951% > -60%

Negative Net Margin

-60%

Negative 3Y Average Net Margin

-557%

Net Margin is Increasing

-2 897% > -60%

Negative Free Cash Flow Margin

-75%

Negative 3Y Average Free Cash Flow Margin

-448%

Free Cash Flow Margin is Increasing

-2 160% > -75%

Negative ROE

-139%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-438%

ROIC is Increasing

-353% > -237%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-60%

Negative 3Y Average Operating Margin

-570%

Operating Margin is Increasing

-2 951% > -60%

Negative Net Margin

-60%

Negative 3Y Average Net Margin

-557%